CARNITOR SF (levocarnitine) by Leadiant Biosciences is clinical pharmacology carnitor (levocarnitine) is a naturally occurring substance required in mammalian energy metabolism. First approved in 1986.
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
CARNITOR SF (levocarnitine) is an oral solution containing a naturally occurring amino acid derivative essential for cellular energy metabolism. It facilitates long-chain fatty acid entry into mitochondria for oxidation and energy production, primarily treating primary and secondary carnitine deficiency. The drug is indicated for patients with inborn errors of metabolism (glutaric aciduria II, methylmalonic aciduria, propionic acidemia, medium-chain fatty acyl-CoA dehydrogenase deficiency) where it clears toxic acylCoA compounds by forming excretable acylcarnitine.
Declining Part D utilization ($7K in 2023, only 34 claims) signals a mature, niche market with minimal commercial expansion opportunities.
CLINICAL PHARMACOLOGY CARNITOR (levocarnitine) is a naturally occurring substance required in mammalian energy metabolism. It has been shown to facilitate long-chain fatty acid entry into cellular mitochondria, thereby delivering substrate for oxidation and subsequent energy production. Fatty acids…
Worked on CARNITOR SF at Leadiant Biosciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Carnitine Analog
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moCareer roles on CARNITOR SF are limited and specialized, focused on maintaining compliance, managing rare-disease relationships, and defending market position in orphan indications. This is not a growth platform for ambitious commercial or development professionals seeking to build high-visibility brands.